Da li je Craneware dividenda sigurna?
Craneware povećava dividendu već 1 godina.
U poslednjih 10 godina, Craneware je ovo povećao/la za 7,640 % godišnje povećana.
Na petogodišnjem nivou porastao isplata je povećana za 2,208 %.
Analitičari očekuju za tekuću poslovnu godinu rast od Povećanje dividendi% na 0,107%.
Craneware Aktienanalyse
Шта ради Craneware?
Craneware PLC is a publicly traded company based in Edinburgh, Scotland, that specializes in the development and marketing of software solutions for the healthcare industry. The company was founded in 1999 and has been listed on the London Stock Exchange since 2007.
The business model of Craneware is based on the development and marketing of software solutions for the healthcare industry that help customers optimize their financial and performance processes. Craneware focuses particularly on the area of Revenue Cycle Management (RCM), which involves the management of hospital billing and payment processes.
Craneware's software solutions are used in various areas, including billing, pricing, contract management, compliance, and analytics. The products are modular and can be individually configured according to the customer's needs.
One example of a product is the Revenue Integrity Management System (RIMS), which allows for comprehensive analysis of patient billing and ensures that hospitals maximize their revenue while complying with regulations.
Other products include Reference Plus, which helps customers determine and stay competitive with pricing for medical services, and the Online Analytics Suite, which specializes in data analysis and reporting.
Craneware is divided into different divisions, including North America, International, and UK & EMEA. North America is the largest market for the company, accounting for approximately 90% of its revenue.
In North America, Craneware has a strong presence and works closely with many large hospitals and healthcare organizations. The company's focus on RCM solutions has received significant attention, and many customers appreciate the efficiency and effectiveness of the software solutions.
In the International division, Craneware focuses on expanding its presence in Europe, Asia, Africa, and the Middle East. The company has already gained many partners in these regions and is working to further expand its market share.
In the UK & EMEA division, Craneware primarily serves NHS hospitals (National Health Service) and offers a wide range of RCM solutions to its customers.
Craneware was founded in 1999 by Edinburgh University graduate Gordon Craig. The company's headquarters were established in Edinburgh and quickly became a major employer in the city.
In 2007, Craneware was listed on the London Stock Exchange and has since been a publicly traded company. In 2015, the company was included in the FTSE AIM 100 Index.
In recent years, Craneware has experienced strong growth and expanded its market presence to different countries. The company plans to continue investing in research and development and focusing on innovation to provide its customers with the best RCM solutions in the future. Craneware je jedna od najpopularnijih kompanija na Eulerpool.com.Plansovi za štednju u akcijama nude atraktivnu mogućnost za investitore da dugoročno izgrade bogatstvo. Jedna od glavnih prednosti je takozvani efekat prosečne cene: investiranjem redovnog fiksnog iznosa u akcije ili fondove akcija, automatski se kupuju više deonica kada su cene niske i manje kada su visoke. To može dovesti do povoljnijeg prosečnog cena po deonici tokom vremena. Pored toga, plansovi za štednju u akcijama omogućuju čak i malim ulagačima pristup skupim akcijama, pošto je moguće učestvovati već sa malim iznosima. Redovno investiranje takođe podstiče disciplinovanu strategiju ulaganja i pomaže da se izbegnu emocionalne odluke, kao što su impulsivno kupovanje ili prodaja. Osim toga, investitori profitiraju od potencijalnog povećanja vrednosti akcija kao i od isplata dividendi, koje se mogu reinvestirati, što pojačava efekat kamate na kamatu i time rast investiranog kapitala.